The Oncology Institute Warrant
TOIIW
TOIIW was delisted on the 31st of July, 2026.
20 hedge funds and large institutions have $4.18M invested in The Oncology Institute Warrant in 2021 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 9 closing their positions.
1.19% less ownership
Funds ownership: 10.74% → 9.55% (-1.2%)
5% less funds holding
Funds holding: 21 → 20 (-1)
11% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 9
24% less capital invested
Capital invested by funds: $5.52M → $4.18M (-$1.34M)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LP
LMR Partners
London,
United Kingdom
|
+$205K |
| 2 |
JG
Jefferies Group
New York
|
+$167K |
| 3 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$140K |
| 4 |
GRIM
Greenhaven Road Investment Management
Greenwich,
Connecticut
|
+$58.1K |
| 5 |
CL
CSS LLC
Chicago,
Illinois
|
+$17.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$577K |
| 2 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$323K |
| 3 |
KC
Kepos Capital
New York
|
-$211K |
| 4 |
RCM
Radcliffe Capital Management
Bala Cynwyd,
Pennsylvania
|
-$199K |
| 5 |
MS
Maven Securities
St Helier,
Jersey
|
-$101K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MS
26
Maven Securities
St Helier,
Jersey
| – | -$101K | -62,500 | Closed |
|
|
MCM
27
Moore Capital Management
New York
| – | -$79K | -62,500 | Closed |
|
|
CCA
28
Castle Creek Arbitrage
Avon,
Colorado
| – | -$31K | -22,000 | Closed |
|
|
RCM
29
Radcliffe Capital Management
Bala Cynwyd,
Pennsylvania
| – | -$199K | -20,000 | Closed |
|
|
MIM
30
Monashee Investment Management
Boston,
Massachusetts
| – | -$30K | -18,749 | Closed |
|
31
Nomura Holdings
Tokyo,
Japan
| – | -$12K | -8,375 | Closed |
|
TOIIW Hedge Fund Activity: Q4 2021 in Review
20 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in The Oncology Institute Warrant (TOIIW) for Q4 2021, worth a combined $4.18M — down 24% from $5.52M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of TOIIW and 8 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 1 added.
The largest buyer was LMR Partners, opening a new position worth an estimated $205K. The largest seller was UBS O'Connor, exiting entirely with an estimated $577K sold.
- 20 institutional investors held The Oncology Institute Warrant (TOIIW) as of Q4 2021, down from 21 in Q3 2021.
- Funds reported $4.18M of The Oncology Institute Warrant stock for Q4 2021, down 24% quarter-over-quarter.
- 8 funds opened new The Oncology Institute Warrant positions in Q4 2021 and 9 closed out, a net change of -1 holder.
- The largest The Oncology Institute Warrant buyer in Q4 2021 was LMR Partners, an estimated $205K added.
- The largest The Oncology Institute Warrant seller in Q4 2021 was UBS O'Connor, an estimated $577K sold.
Based on aggregated 13F filings for Q4 2021.